STAT

MARCH 21, 2024

This information guides the implementation of preventive measures like lifestyle counseling to reduce the risk of ACE-related chronic conditions like depression, obesity, asthma, diabetes, and cancer. It offers physicians a screening tool to evaluate patients, gaining valuable insights into their physical and mental well-being.

Diabetes 274

Diabetes 274

pharmaphorum

AUGUST 19, 2020

UK digital health company Sensyne Health has launched a new smartphone app to help people across the diabetes spectrum manage their condition. The app – called DBm-Health – can help users to monitor their blood glucose levels and send readings, notes and medication information to their healthcare practitioner to assess remotely.

Diabetes 105

Diabetes 105

Express Pharma

OCTOBER 25, 2023

Dr Reddy’s Laboratories announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by its wholly-owned subsidiary, Svaas Wellness. The post Dr Reddy’s launches D2C e-commerce website ‘Celevida Wellness’ for diabetes appeared first on Express Pharma.

Diabetes 119

Diabetes 119

STAT

APRIL 5, 2024

By the year 2020, he opined, “gene-based designer drugs are likely to be available for conditions like diabetes, Alzheimer’s disease, hypertension, and many other disorders.

Diabetes 284

Diabetes 284

Express Pharma

NOVEMBER 9, 2023

A company statement informed, “InsuQuick is a “Make in India” product, developed and manufactured using 100 per cent indigenous technology, and has undergone a robust clinical program to ensure global quality standards. USV and Biogenomics announced the launch of INSUQUICK, biosimilar Insulin Aspart.

Biosimilars 105

Biosimilars Diabetes 105

STAT

JULY 11, 2024

Food and Drug Administration rejected Novo Nordisk’s weekly insulin for treating diabetes in a rare setback for the company , STAT tells us. The FTC said its findings were interim, though, because some companies did not provide all of the requested information, and threatened further action. pharmacies in 2023.

Diabetes 223

Diabetes Packaging 223

STAT

FEBRUARY 1, 2023

Locked behind the firewalls of proprietary systems sits a treasure trove of data that could help diagnose heart disease, diabetes, cancer, and other conditions faster and more accurately and better treat people with them. Read the rest…

Diabetes 237

Diabetes 237

pharmaphorum

JULY 4, 2022

David Weingard, chief impact officer of T1D Moonshot and founder of Cecelia Health, tells us how T1D Moonshot aims to break silos and advance type 1 diabetes prevention and treatment options by utilising numerous partners’ expertise. million Americans live with diabetes, with 1.6 million having type 1 diabetes (T1D).

Diabetes 105

Diabetes 105

Pharmacy Is Right For Me

JANUARY 3, 2024

Additionally, she holds the title of Certified Diabetes Care and Education Specialist (CDCES). She says, “With over 80 different languages spoken at my clinic, I worry that information gets lost in translation. Her professional journey demonstrates the versatility inherent in a pharmacy career. About Clinical Pharmacists.

Diabetes 306

Diabetes Communication 306

STAT

JULY 10, 2024

The FTC said its findings were interim, though, because some companies did not provide all of the requested information and threatened further action. billion prescriptions that were dispensed by U.S. pharmacies in 2023.

Drug Pricing 356

Drug Pricing Diabetes 356

Pharmaceutical Technology

APRIL 12, 2023

Clinical-stage biotechnology firm LyGenesis has formed a joint research collaboration with Imagine Pharma to develop new cell therapies for type 1 diabetes (T1D). In June 2022, the company discovered T1D AIPCs, a critical component to treat T1D through autologous cell transplantation.

Diabetes 98

Diabetes 98

Pharmaceutical Technology

MARCH 28, 2023

Vertex Pharmaceuticals has signed a new non-exclusive licensing agreement with CRISPR Therapeutics to expedite the development of its hypoimmune cell therapies to treat type 1 diabetes (T1D). A Phase I/II study of VCTX211 has been commenced and is currently ongoing. It originated under the partnership of CRISPR Therapeutics and ViaCyte.

Diabetes 94

Diabetes Communication 94

STAT

JULY 15, 2024

European health authorities cautioned that patients due to undergo surgery should be warned of a risk of anesthesia complications if they are being treated with diabetes and weight loss drugs from Novo Nordisk and Eli Lilly, Bloomberg News notes. The

Drug Pricing 203

Drug Pricing Biosimilars Diabetes 203

STAT

JULY 26, 2024

The European Medicines Agency backed the use of Novo Nordisk’s Wegovy to lower major heart risks and strokes in overweight or obese adults without diabetes , Reuters notes. Novo plans to add the prescribing information on the Wegovy label in the EU within about one month. regulator, while the U.S. regulator, while the U.S.

Labelling 253

Labelling Diabetes 253

pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. Collaborating to prevent diabetes. We’ve got two such projects in the UK, in Leicester and Manchester,” says Sahota. “We

Diabetes 111

Diabetes Packaging Communication 111

STAT

SEPTEMBER 13, 2024

insurer is taking an unusually hard line on doctors who it says improperly prescribed the diabetes treatment Ozempic, escalating the ongoing war over drugs that have become wildly popular for weight loss , Bloomberg News reports. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon… A major U.S.

Medical Records 228

Medical Records Labelling Diabetes Drug Pricing 228

Putting Patients First Blog

NOVEMBER 17, 2023

Gabbay, MD, PhD, the ADA’s Chief Science and Medical Officer, American Diabetes Association November is American Diabetes Month® (ADM) at the American Diabetes Association® (ADA). This month often focuses on type 1 and type 2 diabetes. Prediabetes is a condition that comes before diabetes.

Diabetes 106

Diabetes 106

ALiEM - Pharm Pearls

OCTOBER 20, 2023

A 50-year-old Caucasian female with a history of hypertension, coronary artery disease, and insulin-dependent diabetes mellitus presents to the emergency department with a complaint of painful sores on the top of her left foot. It may be equally common in patients without diabetes, hence was renamed without the term “diabeticorum”.

Diabetes 161

Diabetes 161

pharmaphorum

NOVEMBER 8, 2022

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies. Tighter glucose control is known to reduce the risk of complications of diabetes like cardiovascular disease and nerve damage affecting the eyes and extremities. .

Diabetes 64

Diabetes Communication 64

STAT

OCTOBER 27, 2023

The panel committee reviewed non-clinical, clinical, and post-marketing data of the drugs, and said that no updates to their prescribing information was required at the time.

Diabetes 230

Diabetes Drug Development 230

Express Pharma

JULY 11, 2024

The US Food and Drug Administration has declined to approve Novo Nordisk’s weekly insulin in patients with diabetes, the Danish drugmaker said on Wednesday. The regulator’s decision follows its outside panel’s vote against the use of the weekly insulin icodec, in patients with type 1 diabetes due to risks of low blood sugar.

Diabetes 105

Diabetes 105

pharmaphorum

NOVEMBER 30, 2021

Francine Kaufman discusses how Senseonics is helping patients monitor their diabetes with the first fully implantable long-term continuous glucose monitoring (CGM) system. Kaufman has been a practicing pediatric endocrinologist with a focus on diabetes for almost 45 years. She joined the team at Senseonics in 2019.

Diabetes 105

Diabetes 105

STAT

MARCH 21, 2024

Meanwhile, here are a few items of interest to get you started on your own journey, which we hope will be informative and exciting.  Right now, Medicare by law cannot cover obesity drugs, though it will pay for seniors to take the same medicines for conditions like diabetes and heart problems. Our choice today is orange creme.

Diabetes 210

Diabetes 210

STAT

JANUARY 12, 2024

Food and Drug Administration did not find evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts or actions , STAT notes.

Diabetes 233

Diabetes Drug Development 233

Pharmaceutical Technology

AUGUST 14, 2024

population had either pre- or type 2 diabetes. In 2021, the Centers for Disease Control and Prevention estimated that 49 percent of the U.S.

Diabetes 52

Diabetes 52

Express Pharma

MARCH 2, 2025

Union Minister of Chemicals and Fertilizers, and Health and Family Welfare, Jagat Prakash Nadda inaugurated the weeklong celebrations of Jan Aushadhi Diwas, 2025 by flagging off the Rath (Chariot) and 10 other vehicles carrying the information about Pradhan Mantri Bhartiya Janaushadhi Pariyojana from Nirman Bhawan.

Generic Medicine 76

Generic Medicine Diabetes 76

ALiEM - Pharm Pearls

SEPTEMBER 1, 2023

The most common pathogen is Klebsiella pneumoniae, and diabetes mellitus is the most common risk factor. Consider it especially in the patient with abdominal pain with diabetes mellitus. Additional Images Physical Exam Vitals : BP 172/71; HR 127; T 35.9°C; mmol/L; Glucose 538 mg/dL CRP : 42.6 mg/dL Ketone body : 5.9 mmHg; pO2 45.8

Diabetes 161

Diabetes Hospitals 161

The Pharmacist

JUNE 29, 2023

A company which provides online health testing kits has partnered with Superdrug under a two-year deal to help people ‘make informed decisions about their health and lifestyle’.

Diabetes 97

Diabetes 97

Pharma Marketing Network

MARCH 12, 2025

Understanding how patients and healthcare professionals search for medical information is key. Keywords generally fall into three categories: Informational (awareness stage): What are the symptoms of rheumatoid arthritis? best DPP-4 inhibitors for diabetes) keywords balances compliance and visibility. A mix of branded (e.g.,

Diabetes 59

Diabetes 59

Express Pharma

MAY 6, 2024

The new nano carrier could help people with diabetes avoid side-effects linked to insulin injections such as hypoglycemia, inform the researchers Research led by the University of Sydney and Sydney Local Health District has developed a system using nanotechnology that could allow people with diabetes to take oral insulin in the future.

Diabetes 103

Diabetes 103

Express Pharma

JULY 30, 2024

Genpact, a global professional services and solutions firm delivering outcomes that shape the future, has been working with embecta, a global diabetes care company, to support its spin-off from Becton Dickinson and Company (BD) and subsequent evolution as an independent leader in the diabetes technology market.

Diabetes 52

Diabetes 52

pharmaphorum

MARCH 31, 2022

More than 250,000 people living with type 1 diabetes in the UK will be offered real-time continuous glucose monitoring (CGM) technology, reducing their reliance on fingerprick testing, according to NICE. At the moment, flash CGM has been rolled out to around half of patients with type 1 diabetes by NHS England. Exciting news!

Diabetes 52

Diabetes 52

PharmExec

JULY 11, 2024

According to the Complete Response Letter, the FDA has requested additional information on the manufacturing process and the type 1 diabetes indication for insulin icodec before completing its review.

Diabetes 52

Diabetes 52

World Pharma News

JANUARY 22, 2025

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity.

Diabetes 92

Diabetes 92

Pharmacy Times

AUGUST 7, 2024

The ADA Clinical Practice Recommendations added sleep assessment for precision medicine in type 2 diabetes, supporting the wealth of information surrounding the association.

Diabetes 44

Diabetes 44

Viseven

MARCH 27, 2023

This company specializes in biopharmaceuticals, diabetes care, obesity care, and other severe chronic diseases. The partnership aims to redesign healthcare professionals’ access and use of critical information about diabetes care. Interested in building your own Digital Content Factory? Let us know!

Communication 52

Communication Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

JULY 28, 2024

Food and Drug Administration recently warned patients and doctors about dosing errors associated with compounded versions of Novo Nordisk’s weight-loss and diabetes drugs. It urged healthcare providers and compounders to provide the appropriate syringe size and counsel patients on how to measure the dose,” informed the statement.

Compounding 103

Compounding Diabetes 103